GMED
Globus Medical
74.30$
+0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 35.3% | 43.1% | 39.8% | 41.3% | 43.2% | 40.1% | 32.7% | 33.4% | 36.7% | 28.0% | 30.8% | 30.6% | 31.5% | |
| 64.7% | 56.9% | 60.2% | 58.7% | 56.8% | 59.9% | 67.3% | 66.6% | 63.3% | 72.0% | 69.2% | 69.4% | 68.5% | |
| 7.6% | 8.5% | 9.4% | 6.0% | 5.7% | 5.1% | 5.5% | 5.4% | 4.9% | 8.9% | 4.8% | 4.6% | 5.9% | |
| 40.7% | 39.7% | 41.0% | 37.8% | 38.5% | 38.6% | 40.6% | 40.7% | 40.8% | 38.5% | 39.2% | 36.3% | 38.7% | |
| 64.6% | 55.3% | 58.9% | 50.8% | 49.1% | 50.8% | 51.1% | 56.4% | 45.7% | 51.2% | 47.9% | 46.3% | 47.8% | |
| 0.1% | 1.6% | 1.3% | 7.9% | 7.7% | 9.2% | 16.2% | 10.2% | 17.6% | 20.8% | 21.5% | 23.1% | 20.8% | |
| 2.1% | 0.4% | 0.3% | 0.4% | 0.1% | 0.1% | – | 0.1% | 0.2% | – | 0.7% | – | – | |
| 0.7% | 4.1% | -1.4% | 7.6% | 9.1% | 3.8% | 17.3% | 25.2% | 18.7% | 21.1% | 20.7% | 24.0% | 21.1% | |
| 0.4% | 1.6% | -0.2% | 2.5% | 0.8% | -0.3% | 4.7% | -2.0% | 3.3% | 4.0% | 4.3% | 4.8% | 4.1% | |
| 0.3% | 2.4% | -1.2% | 5.0% | 8.3% | 4.0% | 12.6% | 27.2% | 15.5% | 17.0% | 16.4% | 19.2% | 17.0% | |
| 22.5% | 15.8% | 14.0% | 20.1% | 18.5% | 22.1% | 27.4% | 26.0% | 28.0% | 29.6% | 29.9% | 24.0% | 27.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.